Clin2
NCT06542237Possibly a fitRecruiting

Study of a new male birth control pill for healthy men

Male Contraception

Part of Cancer, Genetic & congenital, Hormones & metabolism clinical trials.

This trial tests an experimental birth control pill (YCT-529) taken daily. It aims to see if the drug can safely and effectively prevent pregnancy in healthy men who do not plan to have children in the future.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
88 people
Ages
28 years to 70 years
Study type
Interventional

Who can take part

  • Healthy man aged 28 to 70
  • Decided not to father children (or waiting for a vasectomy)
  • Body mass index between 18 and 35
  • Normal sperm count and quality
  • Not using hormone therapy or certain hair loss drugs in the past 90 days

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07393334Recruiting· Phase 2
Male birth control pill trial

This trial tests a new non-hormonal male contraceptive pill called NLS-133. It is taken just before sex and could help give men more control over family planning.

Seattle, Washington
NCT07361120Recruiting· Phase 2
Plan a vasectomy device study for long-term birth control

This study tests a new device for vasectomy. It's for men who want a long-term birth control option and are in good health, between 25 and 65 years old, with a normal body weight and sperm count.

Maribyrnong, Victoria
NCT07285967Not yet recruiting· Phase 1
Safety study of a new oral tablet in healthy volunteers

This early-phase study tests a new oral tablet (YR011) in healthy volunteers to see how safe it is and how the body processes it. It helps find the right dose for future studies.

NCT07771777Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.

NCT06715540Recruiting· Phase 1
Study of a new drug for healthy male volunteers

This trial tests a new medicine called BCD-261 in healthy men to see if it is safe and how the body processes it. Participants will receive increasing doses and be monitored for about 4 months.

Saint Petersburg
NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang

Hear when a new Male Contraception trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.